Using patient reports to adjust treatment for autoimmune diseases
Part of Bones, joints & muscles, Eyes & vision, Genetic & congenital, Hormones & metabolism, Immune system & allergy, Mouth & dental, Skin clinical trials.
This study looks at whether doctors consider patient “electronic reports” (completed online/phone) when deciding how often to change treatment. It may help improve how well treatment plans match how patients feel over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- Have one of these diagnosed conditions: rheumatoid arthritis, gout, lupus, or Sjögren’s syndrome
- Agree to participate (by consent or non-opposition, depending on country)
- Have reliable internet access plus email and a mobile phone, and be able to use them
- Be able and willing to follow the study for about 2 years and complete the reports
- Not have certain major limits, like a memory/brain disease that affects thinking or an expected life span under 1 year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study collects samples and information from people with rheumatoid arthritis, lupus, or scleroderma, plus healthy volunteers, to better understand how the immune system works in these conditions. By comparing these groups, researchers hope to find new ways to treat and manage autoimmune diseases.
This trial tests whether regular remote check-ins can help manage chronic immunosuppressive medications. If you have an autoimmune condition like rheumatoid arthritis or lupus and are starting a new medicine such as methotrexate or a biologic, you may be eligible.
This study looks at how well people with rheumatoid arthritis (RA) take their RA medicines—especially medicines like methotrexate and other targeted or biologic treatments. It may help improve medication adherence (taking doses correctly) and supports safer, more consistent treatment at home.
This trial tests a new drug called GSK5926371 for people with certain autoimmune diseases that affect the joints, skin, and other tissues. It aims to see if the drug is safe and how well it works.
This study tests if a digital app called RheumaBuddy4.1 can help manage rheumatoid arthritis symptoms. You would use the app at home and report how you feel.
This observational study looks at how people with autoimmune diseases are doing by using medical records and patient questionnaires. It may help researchers better understand long-term patterns of symptoms and care, without testing a new drug.
Hear when a new Gout trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.